Synergy CHC Corporation
03/03/2026 | Press release | Distributed by Public on 03/03/2026 16:21
Material Event (Form 8-K)
Item 8.01 Other Events.
On February 27, 2026, Synergy CHC Corp. (the "Company") was notified by Gravity Pharma General Trading LLC ("Gravity") that Gravity was terminating, ab initio, the Brand License Agreement, dated March 31, 2025, by and between the Company and Gravity (as amended by Amendment No. 1 to the Brand License Agreement, dated June 30, 2025, the "Brand License Agreement").
The Brand License Agreement provided for an exclusive license to sell and market certain FOCUSfactor and Flat Tummy Co. products (the "Licensed IP") in the United Arab Emirates and Turkey (the "Territory") in exchange for an aggregate license fee of $2.9 million. The Company previously accounted for the license fee as revenue.
The Company continues to pursue the registration and marketing of the Licensed IP in the Territory.
Synergy CHC Corporation published this content on March 03, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 03, 2026 at 22:21 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]